A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography
- PMID: 12353239
- DOI: 10.1002/ijc.10666
A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography
Erratum in
- Int J Cancer 2002 Dec 20;102(6):665
Abstract
Female BRCA1/2 mutation carriers develop in up to 50% breast cancer (BC) before age 50 years. We investigated whether the specific histologic features of BRCA1/2-associated breast cancer influence imaging. We correlated the mammographic results with the histology of 34 BC in BRCA1/2 mutation carriers and 34 sporadic cancers in patients, matched for age and year of diagnosis. Mammography was significantly more frequently false-negative in carriers than controls (62% vs. 29% p = 0.01), despite comparable tumor size (mean solidus in circle 1.51 vs. 1.75) and breast density (high 41% vs. 53%). The image in carriers was significantly less as spiculated mass (6 vs. 18 p = 0.01). Cancers of BRCA1/2 mutation carriers had frequently higher mitotic counts (p < 0.0001) and prominent pushing margins around the tumor (p = 0.08) (p = 0.05 for 32 BRCA1). We also observed that prominent "pushing margins" correlated significantly with a false-negative mammography (p = 0.005) and with a mammographic image of a smooth, not a spiculated, mass (p = 0.01). False-negative mammography correlated independently with: BRCA1/2 mutation (p = 0.02), prominent pushing margins (p = 0.03) and high breast density (p = 0.01). MRI was carried out in 12 carriers, had 100% sensitivity and detected 5 cancers, still occult at physical examination and mammography. A BRCA1/2 mutation and high breast density at mammography contribute independently to false-negative mammography results. In mutation carriers any mammographic mass must be regarded with suspicion. Pushing margins of the tumor partly explain these results. For early BC detection in mutation carriers additional methods like MRI may be needed. This may not be necessary in other young women with breast symptoms.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res Treat. 2017 Jun;163(3):565-571. doi: 10.1007/s10549-017-4198-4. Epub 2017 Mar 25. Breast Cancer Res Treat. 2017. PMID: 28343309 Free PMC article.
-
Mammographic, US, and MR imaging phenotypes of familial breast cancer.Radiology. 2008 Jan;246(1):58-70. doi: 10.1148/radiol.2461062173. Radiology. 2008. PMID: 18096529
-
The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls.Eur Radiol. 2006 Dec;16(12):2842-8. doi: 10.1007/s00330-006-0385-0. Epub 2006 Aug 19. Eur Radiol. 2006. PMID: 16924440
-
Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review.
-
Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.Int J Cancer. 2004 Nov 10;112(3):357-64. doi: 10.1002/ijc.20429. Int J Cancer. 2004. PMID: 15382059 Review.
Cited by
-
Intensified surveillance for early detection of breast cancer in high-risk patients.Breast Care (Basel). 2015 Feb;10(1):13-20. doi: 10.1159/000375390. Breast Care (Basel). 2015. PMID: 25960720 Free PMC article. Review.
-
Breast MRI texture analysis for prediction of BRCA-associated genetic risk.BMC Med Imaging. 2020 Jul 29;20(1):86. doi: 10.1186/s12880-020-00483-2. BMC Med Imaging. 2020. PMID: 32727387 Free PMC article.
-
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.Cell Cycle. 2012 Dec 1;11(23):4402-13. doi: 10.4161/cc.22776. Epub 2012 Nov 21. Cell Cycle. 2012. PMID: 23172369 Free PMC article.
-
High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer.Fam Cancer. 2012 Dec;11(4):623-8. doi: 10.1007/s10689-012-9560-4. Fam Cancer. 2012. PMID: 22864640
-
Clinical and epidemiological issues in mammographic density.Nat Rev Clin Oncol. 2011 Dec 6;9(1):33-40. doi: 10.1038/nrclinonc.2011.173. Nat Rev Clin Oncol. 2011. PMID: 22143145 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous